1. Home
  2. PLRX vs DXYZ Comparison

PLRX vs DXYZ Comparison

Compare PLRX & DXYZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pliant Therapeutics Inc.

PLRX

Pliant Therapeutics Inc.

HOLD

Current Price

$1.24

Market Cap

93.3M

Sector

Health Care

ML Signal

HOLD

Logo Destiny Tech100 Inc.

DXYZ

Destiny Tech100 Inc.

HOLD

Current Price

$32.17

Market Cap

447.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLRX
DXYZ
Founded
2015
N/A
Country
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
93.3M
447.0M
IPO Year
2020
2024

Fundamental Metrics

Financial Performance
Metric
PLRX
DXYZ
Price
$1.24
$32.17
Analyst Decision
Hold
Analyst Count
11
0
Target Price
$3.79
N/A
AVG Volume (30 Days)
1.8M
N/A
Earning Date
11-06-2025
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.10
N/A
52 Week High
$14.26
N/A

Technical Indicators

Market Signals
Indicator
PLRX
DXYZ
Relative Strength Index (RSI) 39.33 59.00
Support Level $1.20 $30.07
Resistance Level $1.27 $33.62
Average True Range (ATR) 0.06 3.15
MACD 0.01 -0.11
Stochastic Oscillator 25.81 37.17

Price Performance

Historical Comparison
PLRX
DXYZ

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

About DXYZ Destiny Tech100 Inc.

Destiny Tech100 Inc is a non-diversified, closed-end management investment company. It invests in a portfolio of what is believed to be 100 of the top venture-backed private technology companies.

Share on Social Networks: